trending Market Intelligence /marketintelligence/en/news-insights/trending/-QJfzIqhLd0cFJlmRNvdGg2 content esgSubNav
In This List

Macrocure completes merger with Leap Therapeutics unit

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Macrocure completes merger with Leap Therapeutics unit

Macrocure Ltd. completed its merger with a unit of Cambridge, Mass.-based Leap Therapeutics Inc.

Shareholders of Macrocure will receive 0.1815 common share of Leap per ordinary share of Macrocure canceled, plus cash in place of a fractional common share of Leap.

Trading of Macrocure shares on the Nasdaq Global Market has ceased, and the trading of Leap common stock on the same exchange will begin Jan. 24.